HomeCompareIBXXF vs RYLD

IBXXF vs RYLD: Dividend Comparison 2026

IBXXF yields 17857.14% · RYLD yields 12.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 IBXXF wins by $17047106584171659264.00M in total portfolio value
10 years
IBXXF
IBXXF
● Live price
17857.14%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$17047106584171659264.00M
Annual income
$16,861,361,028,467,424,000,000,000.00
Full IBXXF calculator →
RYLD
RYLD
● Live price
12.14%
Share price
$14.95
Annual div
$1.81
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$44.5K
Annual income
$2,587.35
Full RYLD calculator →

Portfolio growth — IBXXF vs RYLD

📍 IBXXF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodIBXXFRYLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, IBXXF + RYLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
IBXXF pays
RYLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IBXXF
Annual income on $10K today (after 15% tax)
$1,517,857.14/yr
After 10yr DRIP, annual income (after tax)
$14,332,156,874,197,310,000,000,000.00/yr
RYLD
Annual income on $10K today (after 15% tax)
$1,031.60/yr
After 10yr DRIP, annual income (after tax)
$2,199.25/yr
At 15% tax rate, IBXXF beats the other by $14,332,156,874,197,310,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IBXXF + RYLD for your $10,000?

IBXXF: 50%RYLD: 50%
100% RYLD50/50100% IBXXF
Portfolio after 10yr
$8523553292085829632.00M
Annual income
$8,430,680,514,233,712,000,000,000.00/yr
Blended yield
98.91%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IBXXF buys
0
RYLD buys
0
No recent congressional trades found for IBXXF or RYLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricIBXXFRYLD
Forward yield17857.14%12.14%
Annual dividend / share$2.00$1.81
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$17047106584171659264.00M$44.5K
Annual income after 10y$16,861,361,028,467,424,000,000,000.00$2,587.35
Total dividends collected$17034838237245739008.00M$18.8K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: IBXXF vs RYLD ($10,000, DRIP)

YearIBXXF PortfolioIBXXF Income/yrRYLD PortfolioRYLD Income/yrGap
1← crossover$1,796,414$1,785,714.29$11,914$1,213.65+$1.78MIBXXF
2$301,724,280$299,802,117.11$14,099$1,351.30+$301.71MIBXXF
3$47,383,143,508$47,060,298,527.98$16,580$1,494.55+$47383.13MIBXXF
4$6,957,621,293,196$6,906,921,329,642.40$19,384$1,642.61+$6957621.27MIBXXF
5$955,290,364,037,133$947,845,709,253,412.80$22,535$1,794.70+$955290364.01MIBXXF
6$122,648,736,931,019,340$121,626,576,241,499,600.00$26,063$1,950.00+$122648736930.99MIBXXF
7$14,725,168,454,748,666,000$14,593,934,306,232,474,000.00$29,995$2,107.69+$14725168454748.63MIBXXF
8$1,653,272,868,532,626,000,000$1,637,516,938,286,045,300,000.00$34,361$2,266.99+$1653272868532626.25MIBXXF
9$173,593,977,293,677,440,000,000$171,824,975,324,347,530,000,000.00$39,194$2,427.12+$173593977293677440.00MIBXXF
10$17,047,106,584,171,660,000,000,000$16,861,361,028,467,424,000,000,000.00$44,525$2,587.35+$17047106584171659264.00MIBXXF

IBXXF vs RYLD: Complete Analysis 2026

IBXXFStock

Imagion Biosystems Limited provides medical imaging technologies based on superparamagnetic relaxometry for cancer and disease detection, and monitoring therapy. It has activities in nanotechnology; biotechnology; cancer diagnostics; and superparamagnetic relaxometry. The company develops MagSense, which is in Phase I clinical trials for the treatment of HER2 breast cancers; and PrecisionMRX, an iron oxide nanoparticle to detect cancer. Imagion Biosystems Limited has a collaborative research program with Patrys Limited to use the combined technologies for enhancing brain tumor imaging and diagnosis; and a joint development agreement with Global Cancer Technology, Inc. to develop GCT's novel nanoscintillator technology for the treatment of breast cancer. The company was incorporated in 2016 and is based in San Diego, California.

Full IBXXF Calculator →

RYLDETF

The Global X Russell 2000 Covered Call ETF (RYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Russell 2000 BuyWrite Index.

Full RYLD Calculator →
📬

Get this IBXXF vs RYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IBXXF vs SCHDIBXXF vs JEPIIBXXF vs OIBXXF vs KOIBXXF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.